T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alcon
ALC
|
+$2.11B |
| 2 |
Linde
LIN
|
+$1.34B |
| 3 |
American International
AIG
|
+$1.34B |
| 4 |
Marvell Technology
MRVL
|
+$1.28B |
| 5 |
TSS
Total System Services, Inc.
TSS
|
+$1.24B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.27B |
| 2 |
Eli Lilly
LLY
|
+$1.64B |
| 3 |
NVIDIA
NVDA
|
+$1.59B |
| 4 |
RHT
Red Hat Inc
RHT
|
+$1.55B |
| 5 |
Booking.com
BKNG
|
+$1.12B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.92% |
| 2 | Healthcare | 17.37% |
| 3 | Financials | 13.84% |
| 4 | Consumer Discretionary | 13.63% |
| 5 | Industrials | 9.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SKX
1451
DELISTED
Skechers
SKX
| $3.33M | ﹤0.01% |
105,726
+253
| +0.2% | +$7.81K |
|
1452
Bloomin' Brands
BLMN
$924M
| $3.33M | ﹤0.01% |
175,925
+360
| +0.2% | +$7.04K |
|
1453
American Homes 4 Rent
AMH
$12.2B
| $3.32M | ﹤0.01% |
136,718
+25
| +0% | +$600 |
|
1454
Compass Minerals
CMP
$1.12B
| $3.31M | ﹤0.01% |
60,304
+73
| +0.1% | +$4.04K |
|
|
HTGM
1455
DELISTED
HTG Molecular Diagnostics, Inc. Common Stock
HTGM
| $3.31M | ﹤0.01% |
11,071
-54
| -0.5% | -$22.5K |
|
|
Y
1456
DELISTED
Alleghany Corp
Y
| $3.29M | ﹤0.01% |
4,837
+7
| +0.1% | +$4.64K |
|
1457
Old Republic International
ORI
$10.3B
| $3.27M | ﹤0.01% |
146,046
+1,153
| +0.8% | +$25.4K |
|
|
LPT
1458
DELISTED
Liberty Property Trust
LPT
| $3.27M | ﹤0.01% |
65,296
+42
| +0.1% | +$2.06K |
|
1459
EPR Properties
EPR
$4.7B
| $3.25M | ﹤0.01% |
43,572
+13,823
| +46% | +$1.08M |
|
1460
Lamar Advertising Co
LAMR
$15.8B
| $3.24M | ﹤0.01% |
40,174
+35
| +0.1% | +$2.83K |
|
1461
Wyndham Hotels & Resorts
WH
$5.49B
| $3.23M | ﹤0.01% |
57,963
-3,733
| -6% | -$204K |
|
1462
United Therapeutics
UTHR
$21.9B
| $3.22M | ﹤0.01% |
41,253
+19
| +0% | +$1.78K |
|
1463
Teradyne
TER
$64.2B
| $3.21M | ﹤0.01% |
66,922
-61
| -0.1% | -$2.77K |
|
1464
Sonoco
SON
$5.77B
| $3.2M | ﹤0.01% |
48,949
+216
| +0.4% | +$13.6K |
|
|
TWOU
1465
DELISTED
2U Inc
TWOU
| $3.16M | ﹤0.01% |
2,796
-37,164
| -93% | -$54.8M |
|
1466
Travel + Leisure Co
TNL
$4.58B
| $3.14M | ﹤0.01% |
71,558
-1,215
| -2% | -$51.8K |
|
1467
Crown Holdings
CCK
$13.1B
| $3.14M | ﹤0.01% |
51,379
+51
| +0.1% | +$2.97K |
|
1468
ProQR Therapeutics
PRQR
$262M
| $3.13M | ﹤0.01% |
343,925
-119,500
| -26% | -$1.41M |
|
1469
First Solar
FSLR
$24B
| $3.13M | ﹤0.01% |
47,595
+796
| +2% | +$47.9K |
|
1470
Avnet
AVT
$7.87B
| $3.12M | ﹤0.01% |
68,967
+104
| +0.2% | +$4.65K |
|
1471
Trade Desk
TTD
$6.84B
| $3.09M | ﹤0.01% |
135,550
+23,410
| +21% | +$503K |
|
1472
National Fuel Gas
NFG
$7.77B
| $3.08M | ﹤0.01% |
58,427
+176
| +0.3% | +$10K |
|
1473
Polaris
PII
$3.9B
| $3.08M | ﹤0.01% |
33,720
+1,400
| +4% | +$127K |
|
1474
Morningstar
MORN
$7.41B
| $3.06M | ﹤0.01% |
21,188
+26
| +0.1% | +$3.59K |
|
|
PRSP
1475
DELISTED
Perspecta Inc. Common Stock
PRSP
| $3.06M | ﹤0.01% |
130,915
-4,975
| -4% | -$112K |
|
Similar funds
T. Rowe Price Associates's Q2 2019 Portfolio in Review
As of Q2 2019, T. Rowe Price Associates held 2,600 positions worth $712B, up 4.7% from $680B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
T. Rowe Price Associates's Q2 2019 filing shows 72 new, 1,394 increased, 949 reduced and 59 closed positions. Its largest new stake was Alcon: 36,020,796 shares worth $2.23B. The largest sale was UnitedHealth, an estimated $2.27B.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q2 2019 buy was Alcon: 36,020,796 shares worth $2.23B.
- T. Rowe Price Associates added most to Linde in Q2 2019, an estimated $1.34B increase.
- T. Rowe Price Associates's biggest Q2 2019 reduction was UnitedHealth, cutting an estimated $2.27B.
- T. Rowe Price Associates fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $609M.
- T. Rowe Price Associates's ten largest holdings make up 21% of its $712B portfolio in Q2 2019.
- T. Rowe Price Associates opened 72 new positions and closed 59 in Q2 2019.
- T. Rowe Price Associates's portfolio value rose 4.7% quarter-over-quarter to $712B.
Based on T. Rowe Price Associates's 13F filing for Q2 2019, filed 15 Aug 2019.